Enhanced engraftment of HTLV-I-infected human T cells in severe combined immunodeficiency mice by anti-asialo GM-1 antibody treatment

Microbiology and Immunology

Volumn 40, Issue 1, 1996, Pages 39-44

  Ishihara, Shiro ^a   Okayama, Akihiko ^a   Nagatomo, Yasuhiro ^a   Murai, Koichi ^a   Yamashita, Ryozo ^a   Okamoto, Masayuki ^a   Shima, Takashi ^a   Sasaki, Takashi ^a   Mueller, Nancy ^b   Tachibana, Nobuyoshi ^a,c   Tsubouchi, Hirohito ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Oita Prefectural Institute of Health and Environment   (Japan)

Author keywords

Asialo GM 1; HTLV I; MT 2; SCID mouse

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOTETRAOSYLCERAMIDE;

ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CANCER RISK; COMBINED IMMUNODEFICIENCY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; MOUSE; NATURAL KILLER CELL; NONHUMAN; T LYMPHOCYTE; VIRUS CARCINOGENESIS;

EID: 9044225536     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1996.tb03315.x     Document Type: Article

References (23)

1. Barry, T.S., Jones, D.M., Richter, C.B., and Haynes, B.F. 1991. Successful engraftment of human postnatal thymus in severe combined immune deficient (SCID) mice: differential engraftment of thymic components with irradiation versus anti-asialo GM-1 immunosuppressive regimens. J. Exp. Med. 173: 167-180.
2. Bosma, G.C., Custer, R.P., and Bosma, M.J. 1983. A severe combined immunodeficiency mutation in the mouse. Nature 301: 527-530.
3. Dorshkind, K., Pollack, S.B., Bosma, M.J., and Phillips, R.A. 1985. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid). J. Immunol. 134: 3798-3801.
4. Feuer, G., Stewart, S.A., Baird, S.M., Lee, F., Feuer, R., and Chen, I.S.Y. 1995. Potential role of natural killer cells in controlling tumorigenesis by human T-cell leukemia viruses. J. Virol. 69: 1328-1333.
5. Feuer, G., Zack, J.A., Harrington, W.J., Valderama, R., Jr., Rosenblatt, J.D., Wachsman, W., Baird, S.M., and Chen, I.S.Y. 1993. Establishment of human T-cell leukemia virus type I T-cell lymphomas in severe combined immunodeficient mice. Blood 82: 722-731.
6. Habu, S., Fukui, H., Shimamura, K., Kasai, M., Nagai, Y., Okumura, K., and Tamaoki, N. 1981. In vivo effects of anti-asialo GM1. 1. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J. Immunol. 127: 34-38.
7. Henle, G., and Henle, W. 1967. Immunofluorescence, interference, and complement fixation technics in the detection of the herpes-type virus in Burkitt tumor cell line. Cancer Res. 27: 2442-2446.
8. Hill, L.L., Perussia, B., McCue, P.A., and Korngold, R. 1994. Effect of human natural killer cells on the metastatic growth of human melanoma xenografts in mice with severe combined immunodeficiency. Cancer Res. 54: 763-770.
9. Hinuma, Y., Komoda, H., Chosa, T., Kondo, T., Kohakura, M., Takenaka, T., Kikuchi, M., Ichimaru, M., Yunoki, K., Sato, I., Matsuo, R., Takiuchi, Y., Uchino, H., and Hanaoka, M. 1982. Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int. J. Cancer 29: 631-635.
10. Hinuma, Y., Ohta-Hatano, R., Suto, T., and Numazaki, Y. 1969. High incidence of Japanese infants with antibody to a herpes-type virus associated with cultured Burkitt lymphoma cells. Jpn. J. Microbiol. 13: 309-311.
11. Ishihara, S., Tachibana, N., Okayama, A., Murai, K., Tsuda, K., and Mueller, N. 1992. Successful graft of HTLV-I-transformed human T-cells (MT-2) in severe combined immunodeficiency mice treated with anti-asialo GM-1 antibody. Jpn. J. Cancer Res. 83: 320-323.
12. Kiessling, R., Hochman, P.S., Haller, O., Shearer, G.M., Wigzell, H., and Cudkowicz, G. 1977. Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur. J. Immunol. 7: 655-663.
13. Kondo, A., Imada, K., Hattori, T., Yamabe, H., Tanaka, T., Miyasaka, M., Okuma, M., and Uchiyama, T. 1993. A model of in vivo cell proliferation of adult T-cell leukemia. Blood 82: 2501-2509.
14. Kwok, S., Ehrlich, G., Poiesz, B., Kalish, R., and Sninsky, J.J. 1988. Enzymatic amplification of HTLV-I viral sequences from peripheral blood mononuclear cells and infected tissues. Blood 72: 1117-1123.
15. Miyoshi, I., Kubonishi, I., Yoshimoto, S., Akagi, T., Ohtsuki, Y., Shiraishi, Y., Nagata, K., and Hinuma, Y. 1981. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 294: 770-771.
16. Natuk, R.J., and Welsh, R.M. 1987. Accumulation and chemotaxis of natural killer/large granular lymphocytes at sites of virus replication. J. Immunol. 138: 877-883.
17. Ohsugi, T., Ishibashi, K., Shingu, M., and Nomura, T. 1994. Engraftment of HTLV-I-transformed human T-cell line into SCID mice with NK cell function. J. Vet. Med. Sci. 56: 601-603.
18. Pflumio, F., Lapidot, T., Murdoch, B., Patterson, B., and Dick, J.E. 1993. Engraftment of human lymphoid cells into newborn SCID mice leads to graft-versus-host disease. Int. Immunol. 5: 1509-1522.
19. Rowe, M., Young, L.S., Crocker, J., Stokes, H., Henderson, S., and Rickinson, A.B. 1991. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. J. Exp. Med. 173: 147-158.
20. Sambrook, J., Fritsch, E.F., and Maniatis, T. 1989. Analysis of genomic DNA by Southern hybridization, p. 9.31-9.62. In Nolan, C. (ed), Molecular cloning: a laboratory manual, 2nd ed, Cold Spring Harbor Laboratory, New York.
21. Takaori-Kondo, A., Hosono, M., Imada, K., Yao, Z.-S., Sakahara, H., Yamabe, H., Konishi, J., Okuma, M., and Uchiyama, T. 1995. Detection of homing, proliferation, and infiltration sites of adult T cell leukemia cells in severe combined immunodeficiency mice using radiometric techniques. Jpn. J. Cancer Res. 86: 322-328.
22. Takatsuki, K., Uchiyama, T., Sagawa, K., and Yodoi, J. 1977. Adult T cell leukemia in Japan, p. 73-77. In Seno, S., Takaku, F., and Irino, S. (eds), Topics in hematology, Excerpta Medica, Amsterdam.
23. Tanaka, T., Kitamura, F., Nagasaka, Y., Kuida, K., Suwa, H., and Miyasaka, M. 1993. Selective long-term elimination of natural killer cells in vivo by an anti-interleukin-2 receptor p chain monoclonal antibody in mice. J. Exp. Med. 178: 1103-1107.